Your browser is no longer supported. Please, upgrade your browser.
Settings
POAI [NASD]
Predictive Oncology Inc.
Index- P/E- EPS (ttm)-2.38 Insider Own3.70% Shs Outstand48.79M Perf Week-8.93%
Market Cap50.63M Forward P/E- EPS next Y-0.11 Insider Trans0.00% Shs Float46.60M Perf Month-17.07%
Income-26.40M PEG- EPS next Q-0.09 Inst Own2.80% Short Float5.99% Perf Quarter-27.14%
Sales1.30M P/S38.95 EPS this Y67.70% Inst Trans1.46% Short Ratio0.69 Perf Half Y41.86%
Book/sh0.15 P/B6.80 EPS next Y63.30% ROA-116.50% Target Price- Perf Year-32.00%
Cash/sh0.01 P/C72.33 EPS next 5Y- ROE-286.70% 52W Range0.63 - 2.30 Perf YTD39.27%
Dividend- P/FCF- EPS past 5Y62.80% ROI-390.80% 52W High-55.65% Beta1.92
Dividend %- Quick Ratio0.10 Sales past 5Y13.90% Gross Margin64.30% 52W Low61.90% ATR0.12
Employees22 Current Ratio0.20 Sales Q/Q0.00% Oper. Margin- RSI (14)39.94 Volatility5.90% 10.72%
OptionableNo Debt/Eq1.69 EPS Q/Q82.60% Profit Margin- Rel Volume0.27 Prev Close1.06
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume4.06M Price1.02
Recom2.00 SMA20-11.36% SMA50-22.43% SMA200-7.26% Volume1,135,838 Change-3.77%
Apr-27-21 08:30AM  
Apr-21-21 08:17AM  
Mar-23-21 08:30AM  
Mar-15-21 05:15PM  
Mar-08-21 08:30AM  
Feb-24-21 08:30AM  
Feb-23-21 05:30PM  
Feb-18-21 09:00AM  
Feb-17-21 08:30AM  
Feb-16-21 05:00PM  
Feb-11-21 12:30AM  
Feb-08-21 08:30AM  
Feb-02-21 12:00PM  
08:30AM  
Jan-28-21 08:30AM  
Jan-26-21 09:00PM  
Jan-22-21 08:00AM  
Jan-21-21 05:25PM  
Jan-19-21 08:00AM  
Jan-14-21 08:30AM  
Jan-12-21 05:15PM  
Jan-08-21 09:00AM  
Jan-06-21 08:30AM  
Jan-05-21 08:30AM  
Dec-29-20 05:15PM  
Dec-09-20 08:30AM  
Dec-02-20 08:00AM  
Nov-16-20 05:20PM  
Oct-27-20 08:30AM  
Oct-06-20 08:30AM  
Oct-02-20 12:14PM  
Sep-22-20 05:10PM  
Sep-01-20 05:15PM  
Aug-20-20 08:30AM  
Aug-18-20 08:30AM  
Aug-14-20 08:30AM  
Aug-13-20 05:10PM  
Aug-11-20 08:30AM  
Aug-05-20 09:00AM  
Jul-14-20 08:30AM  
Jul-07-20 08:15AM  
Jun-29-20 04:30PM  
Jun-18-20 08:30AM  
Jun-08-20 04:15PM  
Jun-02-20 08:30AM  
May-14-20 08:30AM  
May-07-20 08:00AM  
May-06-20 08:30AM  
Apr-22-20 05:00PM  
08:30AM  
Apr-01-20 08:45AM  
Mar-31-20 08:30AM  
Mar-23-20 08:00AM  
Mar-16-20 09:00AM  
Mar-12-20 08:30AM  
Mar-02-20 08:30AM  
Feb-21-20 08:30AM  
Feb-07-20 02:05PM  
Feb-05-20 08:30AM  
Jan-24-20 12:30PM  
Jan-06-20 09:00AM  
Dec-17-19 08:30AM  
Dec-09-19 08:30AM  
Dec-05-19 08:30AM  
Nov-25-19 08:30AM  
Nov-20-19 08:30AM  
Nov-19-19 08:30AM  
Nov-15-19 05:10PM  
Nov-07-19 08:30AM  
Nov-06-19 08:30AM  
Oct-31-19 08:30AM  
08:30AM  
Oct-30-19 08:30AM  
Oct-24-19 08:30AM  
Oct-02-19 09:57AM  
08:27AM  
08:00AM  
Oct-01-19 05:45PM  
Sep-30-19 01:00PM  
Sep-19-19 08:30AM  
Aug-19-19 08:00AM  
Aug-15-19 05:00PM  
Aug-06-19 08:00AM  
Jul-18-19 08:00AM  
Jun-26-19 08:00AM  
Predictive Oncology Inc. provides various healthcare products and services primarily in the United States. The company operates in three segments: Helomics, Soluble, and Skyline. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers STREAMWAY System, a wall-mounted fully automated system that disposes suction fluid providing uninterrupted performance for physicians while virtually eliminating healthcare workers' exposure to infectious fluids collected during surgical and other patient procedures, as well as proprietary cleaning fluid and filters to users of its systems. The company also provides contract research organization (CRO) and AI-driven predictive models of tumor drug response to improve clinical outcomes to assist pharmaceutical, diagnostic, and biotech industries; and soluble and stable formulations for proteins, including vaccines, antibodies, and other protein therapeutics, as well as develops tumor models for precision cancer therapy and drug development. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence (AI) applied to diseases databases. The company sells its medical device products directly to hospitals and other medical facilities through employed sales representatives, independent contractors, and distributors. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schwartz Carl I.Chief Executive OfficerOct 22Sale0.856405441,611,341Oct 26 05:38 PM
GABRIEL RICHARD LDirectorSep 01Buy0.904,0003,60212,070Sep 02 03:52 PM
GABRIEL RICHARD LDirectorAug 19Buy1.183,0003,5278,070Aug 21 04:09 PM